TrialBMC cancer2015

Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer.

Dimitrios Pectasides et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.